Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7192
+0.0040 (0.56%)
Aug 14, 2025, 11:25 AM - Market open
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $90.84 million as of August 14, 2025. Its market cap has decreased by -73.53% in one year.
Market Cap
90.84M
Enterprise Value
-29.36M
1-Year Change
-73.53%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $90.84M, a decrease of -22.38%. That is a compound annual growth rate of -5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 90.33M | -57.18% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.41B |
| Johnson & Johnson | 414.81B |
| AbbVie | 350.27B |
| UnitedHealth Group | 236.42B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.47B |
| Novo Nordisk | 222.88B |